» Articles » PMID: 10617147

Involvement of Mitogen-activated Protein Kinase in Agonist-induced Phosphorylation of the Mu-opioid Receptor in HEK 293 Cells

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2000 Jan 5
PMID 10617147
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Agonist exposure of many G protein-coupled receptors stimulates an activation of extracellular signal-regulated protein kinases (ERKs) 1 and 2, members of the mitogen-activated protein kinase (MAPK) family. Here, we show that treatment of human embryonic kidney (HEK) 293 cells stably transfected to express the rat micro-opioid receptor (MOR1) with [D-Ala2,MePhe4,Gly5-ol]enkephalin (DAMGO) stimulated a rapid and transient (3-5-min) activation and nuclear translocation of MAPK. Exposure of these cells to the MAPK kinase 1 inhibitor PD98059 not only prevented MAPK activation but also inhibited homologous desensitization of the mu-opioid receptor. We have therefore determined the effect of PD98059 on agonist-induced mu-receptor phosphorylation. DAMGO stimulated a threefold increase in MOR1 phosphorylation within 20 min that could be reversed by the antagonist naloxone. PD98059 produced a dose-dependent inhibition of agonist-promoted mu-receptor phosphorylation with an IC50 of 20 microM. DAMGO also induced MOR1 internalization that peaked at 30 min. Confocal microscopy revealed that DAMGO-induced MOR1 internalization was also largely inhibited in the presence of PD98059. U0126, another chemically unrelated inhibitor of the MAPK cascade, mimicked the effect of PD98059 on mu-receptor phosphorylation and desensitization. MOR1 itself, however, appears to be a poor substrate for MAPK because mu-receptors immunoprecipitated from stably transfected HEK 293 cells were not phosphorylated by exogenous ERK 2 in vitro. The fact that morphine also triggered MAPK activation but did not induce MOR1 internalization indicates that receptor internalization was not required for MOR1-mediated mitogenic signaling. We conclude that MOR1 stimulates a rapid and intemalization-independent MAPK activation. Activation of the MAPK cascade in turn may not only relay mitogenic signals to the nucleus but also trigger initial events leading to phosphorylation and desensitization of the mu-opioid receptor.

Citing Articles

Inhibition of Hsp90 in the spinal cord enhances the antinociceptive effects of morphine by activating an ERK-RSK pathway.

Duron D, Lei W, Barker N, Stine C, Mishra S, Blagg B Sci Signal. 2020; 13(630).

PMID: 32371496 PMC: 9762498. DOI: 10.1126/scisignal.aaz1854.


The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.

Dong S, Liu J, Li L, Wang H, Ma H, Zhao Y Am J Physiol Cell Physiol. 2019; 316(5):C632-C640.

PMID: 30758996 PMC: 6580161. DOI: 10.1152/ajpcell.00443.2018.


STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance.

Kim Y, Kang Y, Park H, Lee J, Yu D, Murata T Exp Mol Med. 2016; 48:e212.

PMID: 26915673 PMC: 4892880. DOI: 10.1038/emm.2016.1.


PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy.

Rojewska E, Popiolek-Barczyk K, Kolosowska N, Piotrowska A, Zychowska M, Makuch W PLoS One. 2015; 10(10):e0138583.

PMID: 26426693 PMC: 4591269. DOI: 10.1371/journal.pone.0138583.


Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Williams J, Ingram S, Henderson G, Chavkin C, Von Zastrow M, Schulz S Pharmacol Rev. 2013; 65(1):223-54.

PMID: 23321159 PMC: 3565916. DOI: 10.1124/pr.112.005942.